These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29702489)

  • 21. Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition.
    Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Kratochvílová H; Křížová J; Trachta P; Mráz M; Haluzík M
    Physiol Res; 2019 Oct; 68(5):817-825. PubMed ID: 31424246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short bowel syndrome in children: current and potential therapies.
    Uko V; Radhakrishnan K; Alkhouri N
    Paediatr Drugs; 2012 Jun; 14(3):179-88. PubMed ID: 22452596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomical and physiological considerations in short bowel syndrome: Emphasis on intestinal adaptation and the role of enterohormones.
    Tappenden KA
    Nutr Clin Pract; 2023 May; 38 Suppl 1():S27-S34. PubMed ID: 37115026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short bowel syndrome: the role of GLP-2 on improving outcome.
    Wallis K; Walters JR; Gabe S
    Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):526-32. PubMed ID: 19474717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal adaptation following resection.
    Tappenden KA
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):23S-31S. PubMed ID: 24586019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum.
    Slim GM; Lansing M; Wizzard P; Nation PN; Wheeler SE; Brubaker PL; Jeppesen PB; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):891-898. PubMed ID: 30614011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of polymeric formula vs elemental formula in neonatal piglets with short bowel syndrome.
    Hua Z; Turner JM; Mager DR; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Wales PW
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):498-506. PubMed ID: 23690158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definitions of intestinal failure and the short bowel syndrome.
    Pironi L
    Best Pract Res Clin Gastroenterol; 2016 Apr; 30(2):173-85. PubMed ID: 27086884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
    Mouillot T; Boehm V; Treton X; Ferrandi E; Kapel N; Cazals-Hatem D; Joly F
    JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):940-943. PubMed ID: 32187383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of short bowel syndrome: Breaking the therapeutic ceiling?
    Wauters L; Joly F
    Nutr Clin Pract; 2023 May; 38 Suppl 1():S76-S87. PubMed ID: 37115030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral Nutrition and Intestinal Failure.
    Bielawska B; Allard JP
    Nutrients; 2017 May; 9(5):. PubMed ID: 28481229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Short bowel syndrome: definition, causes, intestinal adaptation and bacterial overgrowth].
    Ballesteros Pomar MD; Vidal Casariego A
    Nutr Hosp; 2007 May; 22 Suppl 2():74-85. PubMed ID: 17679296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults.
    Zhu C; Li Y
    J Int Med Res; 2022 Mar; 50(3):3000605221086145. PubMed ID: 35343263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of intestinal failure.
    Soondrum K; Hinds R
    Indian J Pediatr; 2006 Oct; 73(10):913-8. PubMed ID: 17090904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
    Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G610-22. PubMed ID: 22744334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the management of short bowel syndrome.
    Jackson C; Buchman AL
    Curr Gastroenterol Rep; 2005 Oct; 7(5):373-8. PubMed ID: 16168235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The colon as an energy salvage organ for children with short bowel syndrome.
    Norsa L; Lambe C; Abi Abboud S; Barbot-Trystram L; Ferrari A; Talbotec C; Kapel N; Pigneur B; Goulet O
    Am J Clin Nutr; 2019 Apr; 109(4):1112-1118. PubMed ID: 30924493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.